STOCK TITAN

FST Financials

KBSX
FY2025 annual
Revenue $48.0M +31.4% YoY
Net Income -$1.5M +53.6% YoY
EPS (Diluted) -$0.03 +66.7% YoY
Free Cash Flow -$1.6M +72.0% YoY
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

FST (KBSX) reported $48.0M in revenue for fiscal year 2025, up 31.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI KBSX FY2025

Sales growth is improving cost absorption, but cash flexibility is still constrained by a tighter balance sheet.

The near-breakeven free cash flow in FY2025 came with operating cash flow still negative at -$1.0M, so most of the improvement reflects capex falling to $603K rather than the core business fully funding itself. At the same time, debt-to-equity rose to 1.9x and the current ratio slipped to 0.9x, meaning lower cash burn did not translate into a looser financing position.

With gross margin essentially flat at 43.0%, the move in operating margin to -4.9% points more to fixed-cost absorption as sales expanded than to a richer mix or pure price increases. That is the pattern of a company getting more use from its cost base, not one whose unit economics suddenly changed.

Inventory fell to $11.8M even as revenue reached $48.0M, a sign that less cash is being trapped in stock and working capital is becoming less of a drag. Even so, cash of $7.2M does not fully offset current liabilities of $30.4M, so day-to-day liquidity remains tight.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 61 / 100
Financial Health Score 61/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of FST's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
73
Dilution
80
R&D Intensity
17
Revenue Progress
77
Burn Trend
85
Balance Sheet
31
Altman Z-Score Distress
1.23

FST scores 1.23, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

FST passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

FST reported a net loss of $1.5M while operations used $1.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

FST reported an operating loss of $2.3M against $658K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$48.0M
YoY+31.4%

FST generated $48.0M in revenue in fiscal year 2025. This represents an increase of 31.4% from the prior year.

EBITDA
-$128K
YoY+92.6%

FST's EBITDA was -$128K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 92.6% from the prior year.

Net Income
-$1.5M
YoY+53.6%

FST reported -$1.5M in net income in fiscal year 2025. This represents an increase of 53.6% from the prior year.

EPS (Diluted)
-$0.03
YoY+66.7%

FST earned -$0.03 per diluted share (EPS) in fiscal year 2025. This represents an increase of 66.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$1.6M
YoY+72.0%

FST recorded an outflow of $1.6M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 72.0% from the prior year.

Cash & Debt
$7.2M
YoY+40.8%

FST held $7.2M in cash against $29.2M in long-term debt as of fiscal year 2025.

Shares Outstanding
45M
YoY+18.6%

FST had 45M shares outstanding in fiscal year 2025. This represents an increase of 18.6% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
43.0%
YoY0.0pp

FST's gross margin was 43.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. That is unchanged from the prior year.

Operating Margin
-4.9%
YoY+5.1pp

FST's operating margin was -4.9% in fiscal year 2025, reflecting core business profitability. This is up 5.1 percentage points from the prior year.

Net Margin
-3.1%
YoY+5.7pp

FST's net profit margin was -3.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.7 percentage points from the prior year.

Return on Equity
-9.7%
YoY+4.5pp

FST's ROE was -9.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.5 percentage points from the prior year.

Capital Allocation

R&D Spending
$1.5M
YoY+15.0%

FST invested $1.5M in research and development in fiscal year 2025. This represents an increase of 15.0% from the prior year.

Capital Expenditures
$603K
YoY-85.4%

FST invested $603K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 85.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

KBSX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

KBSX annual income statement
MetricFY25FY24FY23
Revenue$48.0M+31.4%$36.5M+27.0%$28.7M
Cost of Revenue$27.3M+31.5%$20.8M+36.0%$15.3M
Gross Profit$20.6M+31.3%$15.7M+16.9%$13.4M
R&D Expenses$1.5M+15.0%$1.3M-15.2%$1.5M
SG&A Expenses$12.3M+16.7%$10.5M+14.6%$9.2M
Operating Income-$2.3M+36.0%-$3.6M-16.8%-$3.1M
Interest Expense$658K+29.6%$507K+71.6%$296K
Income Tax-$730K-260.0%$456K+160.7%-$751K
Net Income-$1.5M+53.6%-$3.2M-49.3%-$2.2M
EPS (Diluted)-$0.03+66.7%-$0.09-80.0%-$0.05

KBSX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

KBSX annual balance sheet
MetricFY25FY24FY23
Total Assets$60.9M+4.2%$58.5M-7.7%$63.4M
Current Assets$27.5M+3.1%$26.7M-12.6%$30.5M
Cash & Equivalents$7.2M+40.8%$5.1M-42.7%$8.9M
Inventory$11.8M-18.7%$14.5M-4.4%$15.2M
Total Liabilities$45.4M+27.9%$35.5M-1.2%$35.9M
Current Liabilities$30.4M+37.6%$22.1M+3.5%$21.4M
Long-Term Debt$29.2M+18.0%$24.7MN/A
Total Equity$15.4M-32.4%$22.8M-16.9%$27.5M
Retained Earnings$1.6M-48.7%$3.1M-51.6%$6.3M

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill.

KBSX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

KBSX annual cash flow statement
MetricFY25FY24FY23
Operating Cash Flow-$1.0M+36.6%-$1.6M+85.9%-$11.2M
Capital Expenditures$603K-85.4%$4.1M-64.3%$11.6M
Free Cash Flow-$1.6M+72.0%-$5.7M+74.9%-$22.8M
Investing Cash Flow-$799K+82.1%-$4.5M+61.6%-$11.6M
Financing Cash Flow$3.3M-10.7%$3.7M-67.2%$11.3M
Dividends PaidN/AN/A$2.7M

Not reported in any period shown, so not listed: Share Buybacks.

KBSX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

KBSX annual financial ratios
MetricFY25FY24FY23
Gross Margin43.0%0.0pp43.0%-3.7pp46.8%
Operating Margin-4.9%+5.1pp-10.0%+0.9pp-10.9%
Net Margin-3.1%+5.7pp-8.9%-1.3pp-7.5%
Return on Equity-9.7%+4.5pp-14.2%-6.3pp-7.9%
Return on Assets-2.5%+3.1pp-5.5%-2.1pp-3.4%
Current Ratio0.90-0.3x1.21-0.2x1.43
Debt-to-Equity1.89+0.8x1.08-0.2x1.31
FCF Margin-3.3%+12.3pp-15.7%+63.7pp-79.3%

Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is FST's annual revenue?

FST (KBSX) reported $48.0M in total revenue for fiscal year 2025. This represents a 31.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is FST's revenue growing?

FST (KBSX) revenue grew by 31.4% year-over-year, from $36.5M to $48.0M in fiscal year 2025.

Is FST profitable?

No, FST (KBSX) reported a net income of -$1.5M in fiscal year 2025, with a net profit margin of -3.1%.

FST (KBSX) reported diluted earnings per share of -$0.03 for fiscal year 2025. This represents a 66.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

FST (KBSX) had EBITDA of -$128K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, FST (KBSX) had $7.2M in cash and equivalents against $29.2M in long-term debt.

FST (KBSX) had a gross margin of 43.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

FST (KBSX) had an operating margin of -4.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

FST (KBSX) had a net profit margin of -3.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

FST (KBSX) has a return on equity of -9.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

FST (KBSX) recorded an outflow of $1.6M in free cash flow during fiscal year 2025. This represents a 72.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

FST (KBSX) recorded an outflow of $1.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

FST (KBSX) had $60.9M in total assets as of fiscal year 2025, including both current and long-term assets.

FST (KBSX) invested $603K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

FST (KBSX) invested $1.5M in research and development during fiscal year 2025.

FST (KBSX) had 45M shares outstanding as of fiscal year 2025.

FST (KBSX) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

FST (KBSX) had a debt-to-equity ratio of 1.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

FST (KBSX) had a return on assets of -2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, FST (KBSX) had $7.2M in cash against an annual operating cash burn of $1.0M. This gives an estimated cash runway of approximately 86 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

FST (KBSX) has an Altman Z-Score of 1.23, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

FST (KBSX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

FST (KBSX) reported a net loss of $1.5M while operations used $1.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

FST (KBSX) reported an operating loss of $2.3M against $658K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

FST (KBSX) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top